Radium Ra 223 Dichloride (Xofigo) for the NTX Nuclear Medicine at the Dallas VAMC
This Sources Sought Notice is for informational and planning purposes only and shall not be construed as a solicitation or as an obligation or commitment by the Government. This notice is intended strictly for Market Research. This is a Request for Information only. This is NOT a solicitation for proposals, proposal abstracts, or quotations.
The purpose of this notice is to gain knowledge of potential qualified sources that may be able to provide Radium Ra 223 dichloride (Xofigo) and their size classification/socioeconomic status (service-disabled veteran owned small business, veteran owned small business, women owned small business, HUB Zone, 8(a), small business or large business), relative to NAICS 325412. Responses to this notice will be used by the Government to make appropriate acquisition decisions. A solicitation is not currently available. If a solicitation is issued, it will be announced on Federal Business opportunities website http://www.fbo.gov at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this announcement.
Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.
Please review the attached Statement of Work before responding and please submit all information to Jon Parrocha via e-mail: jon.parrocha@va.gov by 27 October 2017 3:00PM CST.
Jon Parrocha
jon.parrocha@va.gov
